Biocompatible nanomaterials for targeted and controlled delivery of biomacromolecules (Record no. 75949)

MARC details
000 -LEADER
fixed length control field 06112nam a2200769 a 4500
001 - CONTROL NUMBER
control field vtls000079400
003 - CONTROL NUMBER IDENTIFIER
control field MTX
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m eo d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn |||m|||a
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 160715s2013 nyua foab 001 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781606506028 (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781606506004 (print)
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)10707485
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)844954577
035 ## - SYSTEM CONTROL NUMBER
System control number (CaBNvSL)swl00402449
039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE]
Level of rules in bibliographic description 201607151144
Level of effort used to assign nonsubject heading access points staff
-- 201605041227
-- admin
040 ## - CATALOGING SOURCE
Original cataloging agency CaBNVSL
Transcribing agency CaBNVSL
Modifying agency CaBNVSL
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number QP801.P64
Item number K263 2013
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QT 36.5
Item number K263b 2013
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 574.1924
Edition number 23
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
Classification number Ebook
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Kapoor, Deepak N.
9 (RLIN) 115934
245 10 - TITLE STATEMENT
Title Biocompatible nanomaterials for targeted and controlled delivery of biomacromolecules
Medium [electronic resource] /
Statement of responsibility, etc. Deepak N. Kapoor and Sanju Dhawan.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. New York, N.Y. :
Name of publisher, distributor, etc. ASME ;
Place of publication, distribution, etc. New York, N.Y. (222 East 46th Street, New York, NY 10017) :
Name of publisher, distributor, etc. Momentum Press,
Date of publication, distribution, etc. 2013.
300 ## - PHYSICAL DESCRIPTION
Extent 1 electronic text (47 p.) :
Other physical details ill., digital file.
490 1# - SERIES STATEMENT
Series statement Biomedical and nanomedical technologies
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references (p. 38-47) and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note 1. Nanomaterials: a brief introduction --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 2. Tissue and blood-material interactions -- 2.1 Tissue response -- 2.2 Blood response -- 2.3 Cellular response --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 3. Biocompatibility --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 4. Biodegradation --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 5. Biocompatible and biodegradable nanomaterials -- 5.1 Organic nanomaterials -- 5.1.1 Natural and modified natural nanomaterials -- 5.1.2 Synthetic polymeric nanomaterials -- 5.2 Stealth nanomaterials -- 5.3 Inorganic nanomaterials -- 5.3.1 Carbon nanotubes (CNTs) -- 5.3.2 Quantum dots (QDs) -- 5.3.3 End-capped mesoporous silica nanoparticles -- 5.4 Metal nanoparticles -- 5.4.1 Gold nanoparticles (Au-Nps) -- 5.4.2 Silver nanoparticles -- 5.5 Magnetic nanoparticles -- 5.6 Nanocomposites, nanofibres and nanowires -- 5.7 Hybrid nanomaterials -- 5.8 Virus-like nanocarriers -- 5.9 Multifunctional nanoparticles --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 6. Biomacromolecules -- 6.1 Cell penetrating peptides in biomacromolecular delivery -- 6.2 Targeted biomacromolecular delivery --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 7. Challenges in biomacromolecular delivery --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 8. Preparation techniques of biocompatible nanostructures -- 8.1 Top-down techniques -- 8.1.1 Dispersion of preformed polymers -- 8.1.2 Polymerization methods -- 8.1.3 Ionic gelation method for hydrophilic polymers -- 8.1.4 Hybrid assemblies -- 8.2 Bottom-up techniques -- 8.3 Scalable methods --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 9. Characterization and evaluation -- 9.1 Drug-polymer compatibility -- 9.2 Particle size and shape -- 9.3 Zeta potential -- 9.4 Drug release evaluation -- 9.5 Conformational stability -- 9.6 Biocompatibility studies -- 9.7 Pre-clinical evaluation --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 10. Regulatory perspectives --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 11. Industrial viability --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 12. Conclusions -- References.
506 ## - RESTRICTIONS ON ACCESS NOTE
Terms governing access Restricted to libraries which purchase an unrestricted PDF download via an IP.
520 3# - SUMMARY, ETC.
Summary, etc. Nanomaterials are organic or inorganic entities employed for the construction of various nanostructured devices or systems with nanometric dimensions. These nanostructures may include nanoparticles, nanowires, nanotubes, nanocapsules, nanocomposites as well as nanoporous solids. Nanomaterials have gained immense recognition, particularly in biomacromolecular delivery, owing to their capability of controlling the release rate or targeting the therapeutic moieties at molecular, cellular and organ level. Additionally, the problems of conformational and degradation stability associated with biomacromolecules like peptides, proteins, and genes have been addressed successfully by employing these nanomaterials. The degradation products of these biocompatible nanomaterials are non-toxic, non-immunogenic and easily resorbable by the regular physiological processes. The present chapter endeavors to describe the role of nanomaterials in the design, fabrication and development of various nanostructured, biomacromolecular delivery systems and devices. The chapter presents a discussion on various physicochemical properties, preparation techniques and analytical tools for characterizing these systems. The mechanisms of cellular internalization of nanomaterial based targeted systems are also discussed. Taking lead from various successful case studies, the present chapter provides a bird's eye view on the current advances in the field of nanomaterial based biomacromolecular delivery. A brief overview pertaining to the regulatory requirements and commercialization of these systems is also included. Various challenges posed during the development, scale up and large-scale production is also discussed. In a nutshell, besides, providing the salient details about the formulation and applications of biocompatible nanomaterials, the chapter would act as a ready reference for drug delivery scientists, device fabrication engineers and medical researchers working in this area.
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE
Additional physical form available note Also available in print.
538 ## - SYSTEM DETAILS NOTE
System details note Mode of access: World Wide Web.
538 ## - SYSTEM DETAILS NOTE
System details note System requirements: Adobe Acrobat reader.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Title from PDF t.p. (viewed on May 29, 2013).
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Macromolecules.
9 (RLIN) 115935
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nanostructured materials.
9 (RLIN) 115936
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug delivery systems.
9 (RLIN) 115937
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nanomedicine.
9 (RLIN) 115923
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nanostructures.
9 (RLIN) 115938
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Delivery Systems.
9 (RLIN) 115939
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nanomedicine.
9 (RLIN) 115923
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term nanomaterials
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term engineering
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term organic
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term inorganic entities
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term biomacromolecular delivery
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term regulatory requirements
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term commercialization
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term biocompatible
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dhawan, Sanju.
9 (RLIN) 115940
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
International Standard Book Number 9781606506004
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Biomedical & nanomedical technologies.
9 (RLIN) 115941
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://portal.igpublish.com/iglibrary/search/MPB0000077.html">http://portal.igpublish.com/iglibrary/search/MPB0000077.html</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type eBook

No items available.



Office of Academic Resources and Information Technology
      38 Moo. 8, Nawung Sub-District, Muang Phetchaburi District, Phetchaburi 76000 Thailand
    Tel: (032) 708609  Email: library_office@mail.pbru.ac.th